Stock listing

NASDAQ:LTRN Lantern Pharma Inc. Stock

Home listing (NASDAQ) of Lantern Pharma Inc.

Follow Lantern Pharma Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:LTRN

$0.245 USD -0.039 (-13.7%)

Close on Nov 20, 2026

Past year -91.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.229 – $0.283 USDNov 20, 2026
Volume
233,991 sharesNov 20, 2026
Market cap
$3.89M USDAt the close on Nov 20, 2026 · price × 15.89M shares outstanding
52-week range
$0.229 – $4.340 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$260,850 USDMedian day 189,417 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Lantern Pharma Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LTRN · Home$0.245 USD-0.039 (-13.7%)233,991$0.283$0.283$0.229$0.284Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LTRN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.245-0.039-13.7%$0.283$0.283$0.229233,991
$0.284-0.045-13.8%$0.320$0.344$0.280156,867
$0.329-0.036-9.8%$0.360$0.377$0.322307,858
$0.365-0.024-6.2%$0.400$0.400$0.36293,579
$0.389-0.044-10.2%$0.432$0.490$0.382188,533
$0.433-0.028-6.1%$0.460$0.460$0.42288,200
$0.461-0.020-4.2%$0.470$0.520$0.450197,900
$0.481+0.018+3.9%$0.506$0.509$0.470156,000
$0.463-0.136-22.7%$0.650$0.675$0.450379,700
$0.599+0.031+5.5%$0.570$0.630$0.560160,600
$0.568+0.036+6.8%$0.553$0.583$0.500101,500
$0.532-0.055-9.4%$0.580$0.580$0.520166,000
$0.587-0.015-2.5%$0.640$0.640$0.56587,900
$0.602-0.038-5.9%$0.668$0.677$0.581185,500
$0.640-0.021-3.2%$0.700$0.738$0.635176,100
$0.661-0.070-9.6%$0.722$0.741$0.635218,500
$0.731-0.043-5.6%$0.770$0.840$0.730233,100
$0.774+0.134+20.9%$0.656$0.816$0.640603,500
$0.640+0.016+2.6%$0.610$0.650$0.60071,900
$0.624-0.011-1.7%$0.630$0.660$0.601116,100
$0.635-0.006-0.9%$0.650$0.660$0.591196,300
$0.641-0.044-6.4%$0.679$0.709$0.641109,500
$0.685+0.029+4.4%$0.667$0.711$0.667115,700
$0.656+0.015+2.3%$0.626$0.750$0.5981,876,800
$0.641-0.027-4.0%$0.652$0.715$0.640105,800
$0.668+0.001+0.1%$0.684$0.735$0.625257,900
$0.667-0.006-0.9%$0.660$0.706$0.655232,800
$0.673-0.038-5.3%$0.710$0.711$0.651212,300
$0.711-0.026-3.5%$0.724$0.800$0.700162,500
$0.737-0.076-9.3%$0.849$0.850$0.720184,000
$0.813-0.017-2.0%$0.830$0.830$0.760274,900
$0.830-0.080-8.8%$0.889$0.900$0.830250,300
$0.910-0.044-4.6%$0.954$1.000$0.890223,500
$0.954+0.014+1.5%$0.960$1.070$0.920388,600
$0.940+0.080+9.3%$0.880$0.970$0.860276,100
$0.860-0.140-14.0%$1.030$1.040$0.838432,300
$1.000-0.010-1.0%$1.000$1.050$0.982253,600
$1.010-0.075-6.9%$1.100$1.160$0.970420,600
$1.085-0.005-0.5%$1.110$1.120$1.010363,700
$1.090-0.130-10.7%$1.250$1.271$1.080461,400
$1.220+0.010+0.8%$1.190$1.280$1.160219,800
$1.210-0.180-12.9%$1.360$1.360$1.165514,900
$1.390+0.030+2.2%$1.350$1.540$1.340292,200
$1.360-0.140-9.3%$1.450$1.640$1.350747,000
$1.500-0.050-3.2%$1.590$1.625$1.470246,600
$1.550-0.160-9.4%$1.750$1.750$1.550190,300
$1.710-0.220-11.4%$1.930$1.950$1.710277,600
$1.930+0.230+13.5%$1.730$1.960$1.730362,500
$1.700-0.010-0.6%$1.710$1.730$1.670128,100
$1.7100.0000.0%$1.740$1.790$1.710114,400
$1.710-0.050-2.8%$1.775$1.820$1.700109,800
$1.760-0.010-0.6%$1.730$1.869$1.720162,900
$1.770-0.070-3.8%$1.820$1.860$1.760180,700
$1.840-0.065-3.4%$1.860$2.010$1.830242,600
$1.905+0.035+1.9%$1.860$1.930$1.830134,500
$1.870-0.060-3.1%$1.870$1.950$1.810248,700
$1.930-0.090-4.5%$2.050$2.100$1.900162,600
$2.020-0.010-0.5%$2.000$2.140$1.970199,400
$2.030-0.040-1.9%$2.040$2.090$2.000108,000
$2.070-0.090-4.2%$2.170$2.190$2.07091,700
$2.160-0.020-0.9%$2.250$2.300$2.130139,400
$2.1800.0000.0%$2.170$2.260$2.100108,700
$2.180+0.070+3.3%$2.110$2.340$2.100124,000
$2.110-0.230-9.8%$2.270$2.400$2.100150,800
$2.340+0.050+2.2%$2.320$2.410$2.130184,600
$2.290-0.200-8.0%$2.450$2.515$2.250169,100
Ticker
NASDAQ:LTRN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Lantern Pharma (NASDAQ:LTRN) Q2 2026 Earnings Call

    Fri, Aug 14, 2026 · 9:00 AM ET

    Watch Transcript
  • Lantern Pharma (NASDAQ:LTRN) Q4 2025 Earnings Call

    Mon, Mar 30, 2026 · 4:30 PM ET

    Watch Transcript
  • Lantern Pharma (NASDAQ:LTRN) Q3 2025 Earnings Call

    Thu, Nov 13, 2025 · 9:00 AM ET

    Watch Transcript

Latest news

All Lantern Pharma Inc. news

Financings

  • Registered direct offering of common stock (or pre-funded warrants) with concurrent unregistered warrants

    Sep 30, 2026

    Closed: US$4M raised · US$1.09 a share · Warrants at US$1.09 for 60 months · Rodman & Renshaw LLC

    Dealers: Rodman & Renshaw LLC (lead)

    Use of proceeds: Working capital and other general corporate purposes

    Announced Sep 29, 2026 · Closed Sep 30, 2026

Read by 6ix AI from the company's releases

Decks

Lantern Pharma Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
35 in the last 12 months · 186 in all · newest Nov 18, 2026 · oldest 2020
Calls
22 calls with a replay · 22 with a transcript · latest Aug 14, 2026
Decks
35 decks · latest Sep 23, 2026

Where Lantern Pharma Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:LTRN · Home listing · This pageNASDAQUnited StatesUSD
BOATS:LTRNBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Lantern Pharma Inc.